WHO ICTRP trial
Comparison of onset, duration and quality of supraclavicular block using 0.5%…
IRCT20141209020258N158 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20141209020258N158 |
|---|---|
| Public title | Comparison of onset, duration and quality of supraclavicular block using 0.5% bupivacaine with magnesium sulphate , ketamine and neostigmine in forearm orthopedic surgery |
| Scientific title | Comparison of onset, duration and quality of supraclavicular block using 0.5% bupivacaine with magnesium sulphate , ketamine and neostigmine in forearm orthopedic surgery |
| Primary sponsor | Arak University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Forearm orthopedic surgery. Unspecified fracture of forearm;S52.9 |
| Interventions | Intervention 1: ntervention group 1: 25 milliliter of 0.5% bupivacaine with 100 milligram of magnesium sulfate (1 millilite of 10% solution) is prescribed. (Bupivacaine by Strazenka UK-Magnesium Sulfate by Shahid Ghazi Co in Tabriz)… |
| Registration date | May 11, 2021 |
| Target size | 90 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: